Table 1 Antibodies characteristics

From: Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis

Antibody

Reference

Dilution

Ag retrieval (min)

Primary Ab (min)

Anti-c-kit

A4502; Dako, Glostrup, Denmark

1 : 100

30

24

Anti-PDGFR α

AF 307 NA; R&D, Minneapolis, MN, USA

1 : 50

30

32

Anti-PDGFR β

sc-339; Santa Cruz, Santa Cruz, CA, USA

1 : 300

30

32

Anti-M-CSFR

49C10; Cell Signaling, Danvers, MA, USA

1 : 50

30

32

Anti-E cadherin

18-0223; Zymed, Carlsbad, CA, USA

1 : 70

30

24

Anti-β catenin

M3539; Dako

1 : 200

30

32

Anti-p42 map Kinase ERK

9108; Cell Signaling

1 : 100

30

32

Anti-phospho-AKT Ser 473

3787; Cell Signaling

1 : 50

30

32

Anti-phospho-MEK 1/2

2338; Cell Signaling

1 : 50

30

32

Anti-cyclin D1

RM-9104-R7; Neomarkers, Fremont, CA, USA

1

30

24

  1. Abbreviations: Ab=antibody; Ag=antigen; ERK=extracellular signal regulated kinase; M-CSFR=macrophage colony-stimulating factor receptor; PDGFR=platelet derived growth factor.